Off-Year Drug Price Revisions

• MOF Presses for Full FY2027 Drug Price Revision Without Price Gap Thresholds
  November 4, 2026

• Pharma Urges Drug Security, Demands 8.5% Price Hike: LDP Hearing
  October 30, 2026

• Pharma Labor Group Seeks Political Push for Price Hikes, Fair Cost Sharing
  October 30, 2026

• FY2027 Revision: HCPs Press for Action on Drug Shortages, Negative Margins
  October 29, 2026

• Japan to Weigh Necessary Measures for FY2027 Revision: PM
  October 15, 2026

• Takaichi Defends Off-Year Drug Price Revisions as DPP Calls for Abolition
  October 9, 2026

• Provider-Payer Tug-of-War Takes Shape over FY2027 Drug Price Revision
  October 8, 2026

• MHLW to Weigh Survey Data, Past Approach for FY2027 Revision: Official
  September 10, 2026

• Pharma Seeks Inflation-Liked Price Hikes, Freeze on Patent-Period Cuts for 2027 Revision
  August 27, 2026

• Generic Re-Pricing Relief Reaches Just 1 in 10 Unprofitable Products: JGA
  August 27, 2026

• DPP Lawmaker Calls for Inflation Relief in 2027 Off-Year Drug Price Revision
  August 19, 2026

• New Chuikyo Pharmacist Rep Urges 2027 Revision to Stay within 4-Minister Deal
  August 3, 2026

• Chuikyo Kicks Off Debate on FY2027 Off-Year Drug Price Revision
  July 9, 2026

• Chuikyo OKs Drug Price Survey Plan for FY2027 Off-Year Revision
  July 9, 2026

• Labor Group Urges Govt to Scrap FY2027 Off-Year Drug Price Cuts
  July 7, 2026

• DPP Calls for End to Off-Year Drug Price Cuts, Chuikyo Reform
  June 15, 2026

• DPP Leader to Urge Drug Price Hikes, “Freeze” on Off-Year Revisions
  April 17, 2026

• FY2027 Off-Year Drug Price Revision Already Decided: Kenporen Director
  March 24, 2026

• Chuikyo Payers Signal Mixed Views on Off-Year Drug Price Revisions
  February 16, 2026

• Is Calling for an Abolition the Right Play? Rethinking Japan’s FY2027 Off-Year Drug Price Revision
  February 9, 2026

ページ